CorrespondenceIncidence and significance of side branch occlusions following bioresorbable scaffold implantation for long left anterior descending artery lesions
Section snippets
Conflict of interest
Dr. Latib serves on the advisory board for Medtronic. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
References (5)
- et al.
The bioresorbable scaffold: will oversizing affect outcomes?
JACC Cardiovasc Interv
(2016) - et al.
Incidence and short-term clinical outcomes of small side branch occlusion after implantation of an everolimus-eluting bioresorbable vascular scaffold: an interim report of 435 patients in the ABSORB-EXTEND single-arm trial in comparison with an everolimus-eluting metallic stent in the SPIRIT first and II trials
JACC Cardiovasc Interv
(2013)
There are more references available in the full text version of this article.
Cited by (1)
Coronary bifurcation lesions treatment: To safeguard the side branch, it's necessary to be kind to main branch!
2016, International Journal of Cardiology
© 2016 Elsevier Ireland Ltd. All rights reserved.